Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183404 · ClinicalTrials.gov registry record · Phase 2
Long-Term Olanzapine Treatment in Children With Autism
A Phase 2 study, sponsored by Drexel University.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00183404 is a Phase 2 study that has completed, run by Drexel University. The registered enrollment target is 32 participants.
The verdict
NCT00183404, a Phase 2 study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in children.
Interventions
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-09 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183404
The ClinicalTrials.gov registry entry for NCT00183404 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Olanzapine is the first listed.
NCT00183404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183404 about?
NCT00183404 is a clinical study titled "Long-Term Olanzapine Treatment in Children With Autism". This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in children.
What is the current status of trial NCT00183404?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00183404?
The interventions under investigation include: Olanzapine (DRUG).
Who is sponsoring clinical trial NCT00183404?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.